Nevertheless, to test this appealing hypothesis more systematically, we developed and validated novel non-radioactive in vitro assays capable of quantifying autoantibodies to these two GPCR directly and evaluated the prevalence of FSHR-aAb and LHR-aAb in a large cohort of PCOS patients and controls. The gene discussed is LHCGR; the disease is polycystic ovary syndrome.